In contingency of initial failed attempts to tag the endogenous Rif1 gene in mammalian cells for downstream immunofluorescence microscopy and proteomics approaches, the RIF1 gene was deleted in the human breast cancer cell-line MCF-7 using CRISPR/Cas9 technology. In preliminary experiments, Rif1-/- MCF-7 were found to recapitulate the reported phenotypes in Rif1-/- mouse embryonic fibroblast cell-lines, namely, chronic basal activation of the p21 cell-cycle inhibitor, reduced S phase index and slow cellular growth. In downstream experiments, a series of Rif1 domain-deletion transgenes, expressed from an inducible, tetracycline-responsive promoter, were complemented into Rif1-/- in view of enabling the mapping of the minimal sequence requirements for Rif1 localisation to sites of IR-induced DNA damage. This revealed that sequences located within the amino- and carboxyl- terminus of Rif1 are required for its association with chromatin at DNA damage sites. The carboxyl-terminus of Rif1 comprises both reported oligomerisation and BLM interacting sequences, indicates that protein oligomerisation and/or BLM interactions may facilitate Rif1 recruitment to sites of DNA damage. Future studies in which the independent functions and protein interactions mediated by the Rif1 N- and C- terminal domains will enable for a better understanding of Rif1’s function in DNA repair.
In parallel, collaborative published work performed as part of the RAGES MSCIF action contributed to a better understanding of cell-cycle control by the Rif1-interacting protein 53BP1, its upstream regulator during DNA repair, via its function as a p53-regulatory protein (doi: 10.1016/j.molcel.2016.08.002.).